Bile duct cancer, or cholangiocarcinoma, is a malignant tumour of either the bile ducts within the liver (intrahepatic), or those leading from the liver to the small intestine (extrahepatic).

February is National Cancer Awareness Month, a time to amplify discussions on lesser- known but equally devastating ...

Hence, a prospective study with advanced imaging techniques would allow a more confident diagnosis of intrahepatic bile duct cancer. Second, all patients included in our study underwent surgical ...

FOR the 6,000 people in the UK who are newly diagnosed with bile duct cancer every year, the prognosis is uniquely grim. According to data from Cancer Research UK, up to 70 per cent of all these ...

In the current report, we present 24 patients with intrahepatic bile duct dilation and no mass lesion demonstrated on US or CT who underwent resectional treatment under the diagnosis of presumed ...

In the new study, patients diagnosed with the three main types of bile duct cancer (intrahepatic, perihilar or distal cholangiocarcinoma) or with cancer of the gallbladder could be eligible to ...

In the new study, patients diagnosed with the three main types of bile duct cancer (intrahepatic, perihilar or distal cholangiocarcinoma) or with cancer of the gallbladder could be eligible to take ...

11, 2024 /PRNewswire/ -- Pilatus Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its leading molecule, PLT012, for treating ...

gemcitabine single agents), disease indication (intrahepatic bile duct cancer, extrahepatic bile duct cancer), and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies ...